SUMMARY One case of a syndrome simulating a systemic disease is reported. An HLA-B8 patient presented with apparent toxoplasmosis, retinal vein occlusion, autoantibodies against cephalin, contact factors and lipoproteins, immune complexes, rheumatoid factor, and cryoprecipitate. A representation of the immunological mechanisms involved is proposed.
A circulating anticoagulant has already been found in certain normal and pathological conditions: after childbirth, in apparently healthy elderly subjects, in women after parturition, after surgery, in infections, and in malignant and some other diseases such as haemophilia, systemic lupus erythematosus, rheumatoid arthritis, bullous dermatosis, regional enteritis, and hepatic disorders.1 The association of circulating anticoagulant with biological falsepositive reactions for syphilis was reported by Frick, in 1955 ,2 in systemic collagen disease. This circulating anticoagulant is a protein found in the immunoglobulin fraction. Two years later, Laurell and Nilsson3 reported two cases with circulating anticoagulant, false-positive syphilis reactions, and an associated hypergammaglobulinaemia. In 1969, Glueck et al.4 described hyperlipoproteinaemia, dysglobulinaemia, and a coagulation defect with systemic lupus erythematosus, and M'Seffar et al., in 1978,5 reported the association of cryoprotein, immune complexes, and rheumatoid factor in connective tissue diseases.
Toxoplasma infection may be associated with abnormal biological test results such as circulating anticoagulant, false-positive reactions for syphilis, hypergammaglobulinaemia with cryoprecipitate, hyperlipidaemia, immune complexes, and rheumatoid factor and then mimics a systemic disease. We report an HLA-B8 patient with toxoplasmosis, autoimmune abnormalities, and retinal vein occlusion. The problem of this unusual association is reviewed in the light of recent knowledge of immunological mechanisms.
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CASE REPORT
A 50-year-old Caucasian woman was admitted to hospital in November 1977 because of rapidly failing vision. For one year she had had severe left occipital and frontal headaches. The fundus of the right eye was normal, but on the left side the veins were congested and a discrete papillar haemorrhage was visualised. For six months the erythrocyte sedimentation rate had been 34 mm/h. Two months before admission the patient experienced intermittent unilateral blurring of vision. There was a history of goitre but no other relevant history. The patient had not received oestrogen preparations and manifested no cold intolerance. There was a cat in the house but no culture of the pet's faeces had been made. Physical examination of this patient was normal except for a firm thyroid nodule. An electrocardiogram demonstrated a few premature auricular beats. Radiological screening, cerebral and thyroid scans, and bone marrow examination were all normal. Ocular examination showed an abnormal fundus of the left eye with retinal vein occulsion and a visual acuity of 4/200 from 180/200. The cryoprecipitate presented a fibrillar ultrastructure and a proteinaceous appearance (Fig. 1) . CHEMISTRY (6) . This damaged cell debris may act as immunosuppressive products and stimulate suppressor T-lymphocytes (7), which block the reaction of responder T-lymphocytes (8) . (B) Phospholipid glycoprotein complex from damaged cells activates factor VII and thus the extrinsic pathway of blood coagulation (9) . Lipoproteins as new antigenic determinants generate responder T-lymphocytes, leading to T and B cell cooperation (10) with production of different autoantibodies (11), one against cephalin (positive VDRL), one against contact products (circulating anticoagulant), and one against lipoprotein constituting lipoprotein autoantibody immune complex with cryoprecipitation (12) , lipoprotein lipase inhibition, and hyperlipidaemia (13) . Activated coagulation, hyperlipidaemia, and cryoprecipitate cause retinal vein occlusion.
(thermal reversibility) were absent. Two families of serum IgM were considered, one with IgM antibodies directed against Toxoplasma gondii (Fig. 3A) and the other with IgM autoantibodies (Fig. 3B) 
